| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.12. | 3 MedTech Innovators Shaping Healthcare in 2026: AVAH, INGN & CCLD | 1 | Zacks | ||
| AVEANNA HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 08.12. | William Blair initiates Aveanna Healthcare stock with Outperform rating | 3 | Investing.com | ||
| 08.12. | William Blair nimmt Aveanna Healthcare mit "Outperform"-Rating in die Bewertung auf | 1 | Investing.com Deutsch | ||
| 05.12. | Aveanna Healthcare stock price target raised to $13 by Raymond James | 3 | Investing.com | ||
| 14.11. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.11. | Aveanna Healthcare: RBC Kapital bestätigt "Sektor Perform"-Rating und Kursziel von 10 US-Dollar | 1 | Investing.com Deutsch | ||
| 10.11. | Aveanna Healthcare stock holds steady as RBC maintains Sector Perform rating | 2 | Investing.com | ||
| 06.11. | Aveanna outlines 2025 revenue target above $2.375B while expanding preferred payer strategy and integration of Thrive | 1 | Seeking Alpha | ||
| 06.11. | Aveanna Healthcare Holdings Non-GAAP EPS of $0.15 beats by $0.01, revenue of $621.9M beats by $30.72M | 3 | Seeking Alpha | ||
| 06.11. | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | 206 | GlobeNewswire (Europe) | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| 06.11. | Aveanna Healthcare Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum? | 2 | Zacks | ||
| 24.10. | Aveanna Healthcare stock price target raised to $10 from $8 at RBC Capital | 1 | Investing.com | ||
| 24.10. | RBC Capital erhöht Kursziel für Aveanna Healthcare auf 10 US-Dollar | 1 | Investing.com Deutsch | ||
| 22.10. | Aveanna Heathcare dips 8%, prices 10M share secondary offering | 1 | Seeking Alpha | ||
| 22.10. | Aveanna Healthcare: Altaktionäre platzieren Aktienpaket zu 9 US-Dollar | 1 | Investing.com Deutsch | ||
| 22.10. | Aveanna Healthcare selling stockholders price secondary offering at $9 | 1 | Investing.com | ||
| 22.10. | Aveanna Healthcare Holdings, Inc: Aveanna Announces Pricing of Secondary Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 21.10. | Aktienplatzierung durch Großaktionär J.H. Whitney belastet Aveanna-Aktie | 1 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSUS HEALTHCARE | 3,220 | -0,62 % | Basel: Bankenaufsicht will strengere Offenlegungspflichten für SRTs | ||
| ALIGNMENT HEALTHCARE | 18,780 | -1,93 % | Alignment Healthcare, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| BRIGHTSPRING HEALTH SERVICES | 37,750 | +0,05 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| NATERA | 233,64 | -0,81 % | Natera, Inc.: Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer | Multicenter, Signatera Genome-guided interventional trial will evaluate different treatment approaches in HR+/HER2- breast cancer Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA... ► Artikel lesen | |
| PROGYNY | 25,800 | +1,14 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 32,410 | -1,43 % | Promising Growth Forecasts Leading to Analysts' Optimism for Procept Biorobotics (PRCT) | ||
| LIFESTANCE HEALTH GROUP | 7,130 | +0,56 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| HEARTFLOW | 29,830 | -2,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ATRICURE | 40,330 | -0,54 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.09.2025 | The following instruments on XETRA do have their first trading 18.09.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.09.2025
Aktien
1 US64119N6085 Netskope Inc.
2 IE00BFY8C754... ► Artikel lesen | |
| GENEDX | 134,29 | -1,32 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| RXSIGHT | 10,930 | -4,62 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| PACS GROUP | 38,090 | +2,26 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| NUTEX HEALTH | 176,68 | +5,10 % | Nutex Health, Inc.: Nutex Health Responds To Short Seller Report | HOUSTON, Nov. 26, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), is aware of a short seller report issued on November... ► Artikel lesen | |
| ADAPTHEALTH | 10,240 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| CERIBELL | 21,300 | -0,56 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen |